Time
Days to earnings13
Next print2026-10-29
WindowBMO
Fiscal2026-09-30
NYSE · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
MRK
Merck & Company Inc primary
145.45
Full stocks workspace →-0.12-0.1%
Street
Consensus EPS2.144
Consensus revenue17.3B
EPS high / low2.29 / 1.80 · 22.9% · n=19
Rev / avg0 / — · 2.186 / 2.211
Options
IV front25.9%
Implied move5.6%
Put/call full0.74
Put/call front0.59
Short interest
Short shares28.3M / 34.4M · -17.89%
Days to cover2.53
Avg vol · float11.2M · 2.5B
Short % float1.15%
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 13 | 2026-10-29 | 145.45 | 2.144 | 25.9% | 5.6% | +4.2% | -2.2% | +0.4% | -2.0% | 2.29 / 1.80 | 22.9% | 19 | 0.74 | 0 | |
| 2026-10-09 | 14 | 2026-10-29 | 145.57 | 2.186 | 28.3% | 6.6% | +0.9% | -2.2% | +1.1% | -2.7% | 2.34 / 1.80 | 24.7% | 18 | 0.75 | 0 | |
| 2026-10-08 | 15 | 2026-10-29 | 142.41 | 2.186 | 26.9% | 6.4% | -1.0% | -3.8% | -1.6% | -7.0% | 2.34 / 1.80 | 24.7% | 18 | 0.75 | 0 | |
| 2026-10-07 | 16 | 2026-10-29 | 142.76 | 2.186 | 27.3% | 6.7% | -1.8% | -3.6% | -3.2% | -8.8% | 2.34 / 1.80 | 24.7% | 18 | 0.75 | 0 | |
| 2026-10-06 | 17 | 2026-10-29 | 141.95 | 2.186 | 27.3% | 6.9% | -4.9% | -5.9% | -4.4% | -5.8% | 2.34 / 1.80 | 24.7% | 18 | 0.78 | 0 | |
| 2026-10-05 | 18 | 2026-10-29 | 139.54 | 2.206 | 24.9% | 6.4% | -6.2% | -6.7% | -7.2% | -8.5% | 2.34 / 2.01 | 15.0% | 18 | 0.79 | 0 | |
| 2026-10-02 | 19 | 2026-10-29 | 144.31 | 2.206 | 26.9% | 7.3% | -3.0% | -1.7% | -5.3% | -3.1% | 2.34 / 2.01 | 15.0% | 18 | 0.80 | 0 | |
| 2026-10-01 | 20 | 2026-10-29 | 143.81 | 2.206 | 30.3% | 8.4% | -2.8% | -2.3% | -5.2% | -5.5% | 2.34 / 2.01 | 15.0% | 18 | 0.81 | 0 | |
| 2026-09-30 | 21 | 2026-10-29 | 145.39 | 2.206 | 28.8% | 8.1% | -1.8% | +0.3% | -3.0% | +7.6% | 2.34 / 2.01 | 15.0% | 18 | 0.80 | 0 | |
| 2026-09-29 | 22 | 2026-10-29 | 149.32 | 2.206 | 28.3% | 8.1% | -1.1% | +3.8% | +1.1% | +9.8% | 2.34 / 2.01 | 15.0% | 18 | 0.80 | 0 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| PFE primary | Pfizer Inc | 0.53 | 2026Q2 · 2026-08-04 | +13.2% | +0.0% | 25.41 | 16 · 2026-10-12 |
| JNJ primary | Johnson & Johnson | 0.47 | 2026Q2 · 2026-07-15 | +2.1% | -1.5% | 247.02 | 1 · 2026-10-12 |
| ABBV primary | AbbVie Inc | 0.46 | 2026Q2 · 2026-07-31 | +0.3% | -1.9% | 250.94 | 14 · 2026-10-12 |
| LLY primary | Eli Lilly and Company | 0.44 | 2026Q2 · 2026-08-05 | +39.4% | +5.2% | 1,169.86 | 13 · 2026-10-12 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-08-04 | BMO | -0.13 | +50.0% | Beat | +0.5% | -0.4% | 1.45× | +5.6% | Review |
| 2026Q1 | 2026-04-30 | BMO | -1.28 | +12.9% | Beat | -1.5% | -0.1% | 1.79× | +3.9% | Review |
| 2025Q4 | 2026-02-03 | BMO | 2.04 | +1.5% | Beat | -1.5% | +3.7% | 2.07× | +5.0% | Review |
| 2025Q3 | 2025-10-30 | BMO | 2.58 | +9.8% | Beat | -2.3% | +2.0% | 1.78× | +7.7% | Review |
| 2025Q2 | 2025-07-29 | BMO | 2.13 | +4.9% | Beat | -5.0% | +3.5% | 2.58× | -2.8% | Review |
| 2025Q1 | 2025-04-24 | BMO | 2.22 | +3.7% | Beat | -0.6% | +2.0% | 1.08× | -2.7% | Review |
| 2024Q4 | 2025-02-04 | BMO | 1.72 | +3.0% | Beat | -10.8% | +2.0% | 3.98× | -5.7% | Review |
| 2024Q3 | 2024-10-31 | BMO | 1.57 | 0.0% | — | -3.7% | +1.4% | 1.79× | -3.9% | Review |
| 2024Q2 | 2024-07-30 | BMO | 2.28 | +6.5% | Beat | -3.4% | -6.7% | 5.07× | -0.7% | Review |
| 2024Q1 | 2024-04-25 | BMO | 2.07 | +7.8% | Beat | +2.1% | +0.8% | 1.86× | -0.4% | Review |